NCT04133844 (ATECMO) is a clinical trial of Blood sample in Severe Cardiac Insufficiency, sponsored by Rennes University Hospital.

Who is sponsoring NCT04133844?

NCT04133844 is sponsored by Rennes University Hospital.

What drugs are being tested in NCT04133844?

Interventions in NCT04133844: Blood sample.

What condition does NCT04133844 study?

NCT04133844 studies Severe Cardiac Insufficiency.

Is NCT04133844 still recruiting?

NCT04133844 is currently completed. Last updated 4 June 2021.

Last reviewed 2021-06-04 · How we verify

NCT04133844: ATECMO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Antithrombin Deficiency in Patients of Intensive Care Unit Placed on Extracorporeal Membrane Oxygenation

Completed Last updated 4 June 2021

What this trial tests

trial testing Blood sample in Severe Cardiac Insufficiency in 50 participants. Completed in 18 May 2021.

Timeline

5 May 2020

Primary endpoint
18 May 2021

18 May 2021

Quick facts

Lead sponsor	Rennes University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	5 May 2020
Primary completion	18 May 2021
Estimated completion	18 May 2021
Sites	1 location across France

Drugs / interventions tested

Blood sample — full drug profile →

Conditions studied

Severe Cardiac Insufficiency — all drugs for Severe Cardiac Insufficiency →

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Severe Cardiac Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, monocentric, non-interventional study in patients placed on extracorporeal membrane oxygenation (ECMO)

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Antithrombin Levels and Heparin Responsiveness during Venoarterial Extracorporeal Membrane Oxygenation: A Prospective Single-center Cohort Study.
Mansour A, Berahou M, Odot J, Pontis A, et al · · 2024 · cited 14× · PMID 38271619 · DOI 10.1097/aln.0000000000004920
Cumulative exposure to factor XIII deficiency during veno-arterial extracorporeal membrane oxygenation: a prospective cohort study.
Nesseler N, Pontis A, Flécher E, Beaudeau M, et al · · 2026 · PMID 42157260 · DOI 10.1186/s13054-026-06074-x

Verify or expand the search:

Other trials of Blood sample

Trials testing the same drug.

NCT07226466 — Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer · not yet recruiting
NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
NCT06273800 — Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients · NA · recruiting
NCT07030205 — Resting-state Imaging and OSteoporosiS · NA · recruiting
NCT07295808 — Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN) · NA · recruiting

Other Rennes University Hospital trials

Trials by the same sponsor.

NCT07527949 — PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics · NA · not yet recruiting
NCT07449832 — Sperm Epigenome in Hodgkin Lymphoma · NA · not yet recruiting
NCT06950398 — Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers · Phase 2 · not yet recruiting
NCT07188753 — Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-b · NA · not yet recruiting
NCT06898099 — Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04133844 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rennes University Hospital
Last refreshed: 4 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04133844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing